Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KbtxA vs Botox in Essential Blepharospasm
NCT00682760Phase 3Completed
- Start
- Oct 2005
- Primary completion
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Meditoxin in benign essential blepharospasm (BEB) (2 arms). Primary endpoint: Improvement of severity of spasm (SS). Started Oct 2005; status: completed.
02
Drugs
Meditoxin
03
Conditions
benign essential blepharospasm (BEB)
Beyond the preview
Go deeper on NCT00682760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00682760.